Correlation Between Acumen Pharmaceuticals and Telefonica Brasil
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Telefonica Brasil at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Telefonica Brasil into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and Telefonica Brasil SA, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Telefonica Brasil and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Telefonica Brasil. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Telefonica Brasil.
Diversification Opportunities for Acumen Pharmaceuticals and Telefonica Brasil
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between Acumen and Telefonica is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Telefonica Brasil SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telefonica Brasil and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Telefonica Brasil. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telefonica Brasil has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Telefonica Brasil go up and down completely randomly.
Pair Corralation between Acumen Pharmaceuticals and Telefonica Brasil
Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to under-perform the Telefonica Brasil. In addition to that, Acumen Pharmaceuticals is 3.04 times more volatile than Telefonica Brasil SA. It trades about -0.2 of its total potential returns per unit of risk. Telefonica Brasil SA is currently generating about -0.29 per unit of volatility. If you would invest 917.00 in Telefonica Brasil SA on September 3, 2024 and sell it today you would lose (96.00) from holding Telefonica Brasil SA or give up 10.47% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Acumen Pharmaceuticals vs. Telefonica Brasil SA
Performance |
| Timeline |
| Acumen Pharmaceuticals |
| Telefonica Brasil |
Acumen Pharmaceuticals and Telefonica Brasil Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acumen Pharmaceuticals and Telefonica Brasil
The main advantage of trading using opposite Acumen Pharmaceuticals and Telefonica Brasil positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Telefonica Brasil can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telefonica Brasil will offset losses from the drop in Telefonica Brasil's long position.| Acumen Pharmaceuticals vs. DiaMedica Therapeutics | Acumen Pharmaceuticals vs. Lyra Therapeutics | Acumen Pharmaceuticals vs. Centessa Pharmaceuticals PLC |
| Telefonica Brasil vs. Highway Holdings Limited | Telefonica Brasil vs. QCR Holdings | Telefonica Brasil vs. Partner Communications | Telefonica Brasil vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |